Dr. Arthur L. Rosenthal has been a senior technology executive of several major global medical technology companies and a serial entrepreneur over the last 45 years. He is currently a Non-Executive Director and the Chair of Compensation Committee for LivaNova, PLC, a UK global medical technology company and Professor of Practice, Emeritus, Department of Biomedical Engineering, Boston University.
Prior, Dr. Rosenthal served on the Cyberonics (vagal nerve stimulation) board of directors as a Non-Executive Director and the Chair of the Compensation Committee from 2007 to 2015. From 2011 to 2012, he served as the Executive Vice Chairman of Cappella Medical Devices Ltd., a development-stage company focused on novel stent solutions for coronary artery disease. From 2009 to 2011, he served as President and CEO of Cappella, Inc. He served as Chairman, from 2002, and CEO, commencing in 2005, of Labcoat, Ltd. (engineering drug coating) until its acquisition by Boston Scientific Corporation in 2008.
In 2011, he was the cofounder and CEO of gEyecue, Inc., a development stage medical device company working on a guided biopsy for lower and upper gastrointestinal cancer screening. From 1994 to 2000, he was the Chief Development Officer of Boston Scientific, and from 2000 until his retirement in 2005, the Chief Scientific Officer. Dr. Rosenthal served as a Non-Executive Director, and from 2006 through 2009, as the Chairman of the Remuneration Committee, of Renovo, Ltd., a U.K.-based pharmaceutical company that became publicly traded in 2006. In 2009, he joined the board of Interface Biologics, Inc., a Toronto-based development stage company focused on drug delivery devices, as a Non-Executive Director. In 2011, he was elected Chairman at Interface Biologics, Inc.
From 2013 to 2015, he served as a Non-Executive Director and Member of the Compensation Committee of Arch Technologies, Inc. and is currently a Clinical Advisory Board member. In 2015, Dr. Rosenthal was appointed to the Industrial Advisory Committee, CURAM (National University in Galway, Ireland). Dr. Rosenthal has been a Fellow of the American Institute of Medical and Biological Engineering (AIMBE) since 2003.